Myelodysplastic syndrome (MDS) codes

Coding system: SNOMED CT (UK Clinical Edition)
Coding system release: 39.2.0
Organisation: NHSD Primary Care Domain Refsets
Codelist ID: nhsd-primary-care-domain-refsets/myelodysplastic-syndrome-mds-codes
Version Tag: 20241205
Version ID: 6c28a1fa

Versions

Description

Taken from the MDS_COD refset published by NHSD.

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

Search:

code	term
4227006	Myelodysplastic syndrome
21721006	Acute myelofibrosis
22265001	Myelosclerosis with myeloid metaplasia
52220008	Acute megakaryoblastic leukemia
52967002	Myelofibrosis
80570006	Acute panmyelosis with myelofibrosis
94148006	Megakaryocytic leukemia in remission
109991003	Acute panmyelosis with myelofibrosis
109993000	Chronic myeloproliferative disorder (clinical)
109995007	Myelodysplastic syndrome
109996008	Myelodysplastic syndrome: Refractory anemia, without ringed sideroblasts, without excess blasts
109998009	Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia
110000005	Refractory anemia with excess blasts in transformation
123306007	Refractory anemia
127225006	Chronic myelomonocytic leukemia
128623006	Myelodysplastic neoplasm
128830003	Therapy-related acute myeloid leukemia and myelodysplastic syndrome
128836009	Myelodysplastic syndrome with multilineage dysplasia
128837000	Myelodysplastic syndrome with isolated deletion 5q
128838005	Therapy-related myelodysplastic syndrome
128843003	Primary myelofibrosis
128845005	Refractory anemia
128846006	Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia
128847002	Myelodysplastic syndrome with increased blasts
128848007	Refractory anemia with excess blasts in transformation
188757003	Acute myelofibrosis
189509003	Refractory anemia without sideroblasts, so stated
189510008	Refractory anemia with sideroblasts
189511007	Refractory anemia with excess of blasts
189512000	Refractory anemia with excess of blasts with transformation
189515003	(Myelodysplastic syndrome, unspecified) or (myelodysplasia)
189516002	[X]Refractory anaemia, unspecified
190222001	[X]Neoplasm of uncertain and unknown behavior of other myelodysplastic syndromes
190228002	[X]Refractory anemia, unspecified
190229005	[X]Myelodysplastic syndrome, unspecified
191267001	Refractory anaemia
267440005	Monoclonal paraproteinemia
277589003	Myelodysplastic-myeloproliferative neoplasm with neutrophilia
277595002	Refractory anemia with ringed sideroblasts
277596001	Refractory anemia with excess blasts in transformation
277597005	Myelodysplastic syndrome with isolated del(5q)
277602003	Acute megakaryoblastic leukemia
307651005	Primary myelofibrosis
373381004	Myelodysplastic syndrome, no International Classification of Diseases for Oncology subtype
393565000	Myelodysplastic syndrome
397336008	Myelodysplastic-myeloproliferative neoplasm
397337004	Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
397338009	Myelodysplastic neoplasm with increased blasts-1
397339001	Myelodysplastic neoplasm with increased blasts-2
397341000	Acute myeloid leukemia with multilineage dysplasia following a myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disorder
397343002	Therapy-related acute myeloid leukemia and myelodysplastic syndrome, alkylating agent-related type
397344008	Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type
398623004	Myelodysplastic syndrome with excess blasts
414791003	Myelodysplastic syndrome, unclassified by World Health Organization classification
415283002	Myelodysplastic syndrome with excess blasts-1
415284008	Myelodysplastic syndrome with excess blasts-2
415285009	Myelodysplastic syndrome with multilineage dysplasia
415286005	Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia
425333006	Myeloproliferative disorder
445448008	Acute myeloid leukemia with myelodysplasia-related changes
445738007	Myelodysplastic/myeloproliferative disease
447240002	Myelodysplastic/myeloproliferative neoplasm, unclassifiable
447596005	Myelodysplastic/myeloproliferative neoplasm, unclassifiable
450945008	Refractory cytopenia with unilineage dysplasia
450946009	Refractory neutropenia
450947000	Refractory thrombocytopenia
699293000	Ischemic myelofibrosis
700057001	Emberger syndrome
702476004	Therapy-related myelodysplastic syndrome
703817002	Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
705061009	Childhood myelodysplastic syndrome
721302006	Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
721303001	Refractory neutropenia
721304007	Refractory thrombocytopenia
721306009	Therapy related acute myeloid leukemia and myelodysplastic syndrome
766045006	Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
766048008	Acute myeloid leukemia and myelodysplastic syndrome related to radiation
775909002	Congenital neutropenia, myelofibrosis, nephromegaly syndrome
778006008	Autosomal dominant aplasia and myelodysplasia
780817000	Undifferentiated myeloproliferative disease
789435006	Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia
871540009	Myelofibrosis due to and following polycythemia vera
871541008	Myelofibrosis due to and following essential thrombocythemia
1144955001	Vasculitis due to myeloproliferative disorder
1153341001	Myeloproliferative hypereosinophilic syndrome
1153345005	Myelodysplastic syndrome with single lineage dysplasia
1153374001	Myelofibrosis caused by drug
1172699002	Hereditary thrombocytopenia with early-onset myelofibrosis
1204344007	Myelodysplastic syndrome with single lineage dysplasia
1234831009	Myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital anomalies, enteropathy syndrome
1251390005	Occlusion of microvasculature of skin due to platelet thrombus associated with myeloproliferative disorder
1251513007	Myelodysplastic and myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis
1251519006	Myelodysplastic neoplasm with low blasts
1251568006	Myelodysplastic neoplasm with biallelic TP53 inactivation
1251582006	Myelodysplastic neoplasm of childhood
1251583001	Myelodysplastic neoplasm of childhood with low blasts
1251584007	Myelodysplastic neoplasm of childhood with increased blasts
1251598004	Myelodysplastic neoplasm with low blasts and SF3B1 mutation
1255668009	Myeloproliferative neoplasm unclassifiable
1260217004	Myelodysplastic neoplasm with low blasts and SF3B1 mutation
1260268001	Myelodysplastic syndrome with low blasts
1260269009	Hypoplastic myelodysplastic syndrome
1260270005	Hypoplastic myelodysplastic syndrome
1260406003	Myelodysplastic neoplasm with biallelic TP53 inactivation
1264416003	Unclassifiable myelodysplastic syndrome
292551000000103	[M] Refractory anaemia with excess of blasts
351251000119103	Acute myelofibrosis in remission
389761000000108	[X]Myelodysplastic syndrome, unspecified
390651000000106	[X]Neoplasm of uncertain and unknown behaviour of other myelodysplastic syndromes
402761000000108	[X]Refractory anaemia, unspecified
420441000000109	[M]Acute myelofibrosis
462371000000101	[X]Refractory anemia, unspecified
815001000000105	Myelodysplastic/myeloproliferative disease
815311000000105	Acute myeloid leukemia with myelodysplasia-related changes
820601000000103	Refractory anaemia with multilineage dysplasia
832921000000100	5Q minus syndrome
833071000000106	Myelodysplastic and myeloproliferative disease
833081000000108	Refractory anaemia without sideroblasts, so stated
833091000000105	[M] Refractory anaemia with sideroblasts
833111000000100	Refractory anaemia with multilineage dysplasia
833461000000109	Acute myeloid leukaemia with myelodysplasia-related changes

Showing 1 to 121 of 121 entries

Codes not in the full codelist are in faint grey.

Disorder

Autosomal dominant aplasia and myelodysplasia(778006008)

Hereditary thrombocytopenia with early-onset myelofibrosis(1172699002)

Myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital anomalies, enteropathy syndrome(1234831009)

Myelofibrosis(52967002)

Myeloproliferative disorder(425333006)

├Chronic myeloproliferative disorder (clinical)(109993000)

│├Chronic eosinophilic leukemia(188733003)

│├Chronic myeloid leukemia(92818009)

│├Chronic neutrophilic leukemia(188734009)

│├Juvenile myelomonocytic leukemia(445227008)

│├Myeloproliferative hypereosinophilic syndrome(1153341001)

│├Polycythemia vera(109992005)

│└Primary myelofibrosis(307651005)

├Isolated bone marrow mastocytosis(1231735008)

├Myelodysplastic syndrome(109995007)

│├Childhood myelodysplastic syndrome(705061009)

│├Hypoplastic myelodysplastic syndrome(1260270005)

│├Monosomy 7 syndrome(307340003)

│├Myelodysplastic neoplasm with biallelic TP53 inactivation(1260406003)

│├Myelodysplastic syndrome with excess blasts(398623004)

│├Myelodysplastic syndrome with isolated del(5q)(277597005)

│├Myelodysplastic syndrome with low blasts(1260268001)

││├Congenital progressive bone marrow failure, B-cell immunodeficiency, skeletal dysplasia syndrome(1177173001)

││├Myelodysplastic neoplasm with low blasts and SF3B1 mutation(1260217004)

││├Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia(109998009)

││└Refractory thrombocytopenia(721304007)

│├Refractory anaemia with multilineage dysplasia(820601000000103)

│└Unclassifiable myelodysplastic syndrome(1264416003)

├Myelodysplastic/myeloproliferative disease(445738007)

├Myeloid leukemia(188732008)

│├Acute myeloid leukemia(91861009)

││├Acute megakaryoblastic leukemia(277602003)

││├Acute monocytic leukemia(413441006)

││├Acute myeloid leukemia in remission(91860005)

│││├Acute monocytic leukemia in remission(91858008)

│││├Acute myeloid leukemia in complete remission(1162531007)

│││├Acute myeloid leukemia with maturation, FAB M2, in remission(426124006)

│││├Acute myelomonocytic leukemia, FAB M4, in remission(427658007)

│││├Acute promyelocytic leukemia, FAB M3, in remission(425869007)

│││├Erythroleukemia, FAB M6 in remission(426642002)

│││└Megakaryocytic leukemia in remission(94148006)

││├Acute myeloid leukemia with 11q23 abnormality(1157157006)

││├Acute myeloid leukemia with BCR-ABL1(1237368006)

││├Acute myeloid leukemia with CBFB::MYH11 fusion(838355002)

││├Acute myeloid leukemia with CCAAT/enhancer binding protein alpha somatic mutation(764855007)

││├Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1(780844005)

││├Acute myeloid leukemia with maturation, FAB M2(359648001)

││├Acute myeloid leukemia with myelodysplasia-related changes(445448008)

││├Acute myeloid leukemia with normal karyotype(703387000)

││├Acute myeloid leukemia with nucleophosmin 1 somatic mutation(763309005)

││├Acute myeloid leukemia with t(6;9)(p23;q34) translocation(733598001)

││├Acute myeloid leukemia with t(8;16)(p11;p13) translocation(725390002)

││├Acute myeloid leukemia with t(8;21)(q22;q22) RUNX1-RUNX1T1(1148906001)

││├Acute myeloid leukemia without maturation, FAB M1(359640008)

││├Acute myeloid leukemia, minimal differentiation, FAB M0(359631009)

││├Acute myelomonocytic leukemia, FAB M4(110005000)

││├Acute panmyelosis with myelofibrosis(109991003)

││├Acute promyelocytic leukemia, FAB M3(110004001)

││├Basophilic leukemia(307592006)

││├Core binding factor acute myeloid leukemia(702446006)

││├Erythroleukemia, FAB M6(93451002)

││├Inherited acute myeloid leukemia(764940002)

││├Leukemic infiltration of skin in acute myeloid leukemia(404152006)

││├Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)(763796007)

││├Myeloid leukemia associated with Down syndrome(724644005)

││├Refractory acute myeloid leukemia(12291000132102)

││└Relapsing acute myeloid leukemia(12281000132104)

│├Chloroma(188737002)

│├Chronic myeloid leukemia(92818009)

│├Leukemic infiltration of skin in myeloid leukemia(404151004)

│├Monocytic leukemia(188744006)

│├Myeloid leukemia in remission(94716000)

││├Acute myeloid leukemia in remission(91860005)

│││├Acute monocytic leukemia in remission(91858008)

│││├Acute myeloid leukemia in complete remission(1162531007)

│││├Acute myeloid leukemia with maturation, FAB M2, in remission(426124006)

│││├Acute myelomonocytic leukemia, FAB M4, in remission(427658007)

│││├Acute promyelocytic leukemia, FAB M3, in remission(425869007)

│││├Erythroleukemia, FAB M6 in remission(426642002)

│││└Megakaryocytic leukemia in remission(94148006)

││├Chronic myeloid leukemia in remission(92817004)

││└Juvenile myelomonocytic leukemia in remission(788972003)

│├Myelomonocytic leukemia(188768003)

││├Acute myelomonocytic leukemia, FAB M4(110005000)

││├Chronic myelomonocytic leukemia(127225006)

││├Juvenile myelomonocytic leukemia(445227008)

││└Subacute myelomonocytic leukemia(188770007)

│└Neutrophilic leukemia(307617006)

├Therapy-related myelodysplastic syndrome(702476004)

│├Acute myeloid leukemia and myelodysplastic syndrome related to radiation(766048008)

│├Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor(766046007)

│├Therapy related acute myeloid leukemia and myelodysplastic syndrome(721306009)

│└Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent(762315004)

│ └Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent(766045006)

└Transient abnormal myelopoiesis(721307000)

Occlusion of microvasculature of skin due to platelet thrombus associated with myeloproliferative disorder(1251390005)

Vasculitis due to myeloproliferative disorder(1144955001)

Morphologic Abnormality

Acute megakaryoblastic leukemia(52220008)

Myelodysplastic neoplasm(128623006)

Myelodysplastic-myeloproliferative neoplasm(397336008)

├Chronic myelomonocytic leukemia(128831004)

├Myelodysplastic and myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis(1251513007)

├Myelodysplastic and myeloproliferative neoplasm with neutrophilia(128826001)

└Myelodysplastic/myeloproliferative neoplasm, unclassifiable(447240002)

Myeloproliferative neoplasm unclassifiable(1255668009)

Primary myelofibrosis(128843003)

[Inactive] Disorder

(Myelodysplastic syndrome, unspecified) or (myelodysplasia)(189515003)

Acute myelofibrosis(188757003)

Acute myelofibrosis in remission(351251000119103)

Acute myeloid leukemia with myelodysplasia-related changes(815311000000105)

Monoclonal paraproteinemia(267440005)

Myelodysplastic syndrome(393565000)

Myelodysplastic syndrome with multilineage dysplasia(415285009)

Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia(415286005)

Myelodysplastic syndrome with single lineage dysplasia(1153345005)

Myelodysplastic syndrome, unclassified by World Health Organization classification(414791003)

Myelodysplastic syndrome: Refractory anemia, without ringed sideroblasts, without excess blasts(109996008)

Myelodysplastic/myeloproliferative disease(815001000000105)

Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis(721302006)

Refractory anaemia(191267001)

Refractory anemia(123306007)

Refractory anemia with excess blasts in transformation(277596001)

Refractory anemia with excess blasts in transformation(110000005)

Refractory anemia with excess of blasts(189511007)

Refractory anemia with excess of blasts with transformation(189512000)

Refractory anemia with ringed sideroblasts(277595002)

Refractory anemia with sideroblasts(189510008)

Refractory anemia without sideroblasts, so stated(189509003)

Refractory neutropenia(721303001)

[X]Myelodysplastic syndrome, unspecified(190229005)

[X]Myelodysplastic syndrome, unspecified(389761000000108)

[X]Neoplasm of uncertain and unknown behavior of other myelodysplastic syndromes(190222001)

[X]Neoplasm of uncertain and unknown behaviour of other myelodysplastic syndromes(390651000000106)

[X]Refractory anaemia, unspecified(402761000000108)

[X]Refractory anaemia, unspecified(189516002)

[X]Refractory anemia, unspecified(190228002)

[X]Refractory anemia, unspecified(462371000000101)

[Inactive] Morphologic Abnormality

Acute myelofibrosis(21721006)

Acute myeloid leukemia with multilineage dysplasia following a myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disorder(397341000)

Acute panmyelosis with myelofibrosis(80570006)

Myelodysplastic syndrome(4227006)

Myelodysplastic syndrome with multilineage dysplasia(128836009)

Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia(789435006)

Myelodysplastic syndrome with single lineage dysplasia(1204344007)

Myelodysplastic syndrome, no International Classification of Diseases for Oncology subtype(373381004)

Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis(703817002)

Myelosclerosis with myeloid metaplasia(22265001)

Refractory anemia(128845005)

Refractory anemia with excess blasts in transformation(128848007)

Refractory cytopenia with multilineage dysplasia and ringed sideroblasts(397337004)

Refractory cytopenia with unilineage dysplasia(450945008)

Refractory neutropenia(450946009)

Refractory thrombocytopenia(450947000)

Therapy-related acute myeloid leukemia and myelodysplastic syndrome(128830003)

Therapy-related acute myeloid leukemia and myelodysplastic syndrome, alkylating agent-related type(397343002)

Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type(397344008)

Therapy-related myelodysplastic syndrome(128838005)

[M]Acute myelofibrosis(420441000000109)

[Inactive] Unknown

5Q minus syndrome(832921000000100)

Acute myeloid leukaemia with myelodysplasia-related changes(833461000000109)

Myelodysplastic and myeloproliferative disease(833071000000106)

Refractory anaemia with multilineage dysplasia(833111000000100)

Refractory anaemia without sideroblasts, so stated(833081000000108)

[M] Refractory anaemia with excess of blasts(292551000000103)

[M] Refractory anaemia with sideroblasts(833091000000105)